1402931-85-4
Chemical Structure
eIF4A-IN-3
- CAS No.: 1402931-85-4
- Formula:C28H28ClNO6
- Molecular Weight:509.98
IUPAC Name: tert-butyl (1R,3R)-3-((tert-butyldimethylsilyl)oxy)-1-((tert-butylsulfinyl)amino)-8-azaspiro[4.5]decane-8-carboxylate
InChIKey: QGAOOBALZRBQLX-GWNOIRNCSA-N
SMILES: COC1=CC=C([C@@]23OC4=CC(Cl)=CC(OC)=C4[C@]2(O)[C@@H]([C@@H]([C@H]3C5=CC=CC=C5)C(N(C)C)=O)O)C=C1
Biological Activity: eIF4A-IN-3, Silvestrol (HY-13251) analogue, is an eIF4A inhibitor. eIF4A-IN-3 blocks protein translation initiation by interfering with eIF4F complex assembly, preferentially inhibiting translation of mRNAs with long, highly structured 5'-untranslated regions. eIF4A-IN-3 inhibits proliferation of human breast cancer cells. eIF4A-IN-3 has moderate apical to basolateral permeability in intestinal cell monolayers and a low efflux ratio[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
eIF4A-IN-3 | 99.92% | eIF4A-IN-3, Silvestrol (HY-13251) analogue, is an eIF4A inhibitor. eIF4A-IN-3 blocks protein translation initiation by interfering with eIF4F complex assembly, preferentially inhibiting translation of mRNAs with long, highly structured 5'-untranslated regions. eIF4A-IN-3 inhibits proliferation of human breast cancer cells. eIF4A-IN-3 has moderate apical to basolateral permeability in intestinal cell monolayers and a low efflux ratio. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
